Which outcome is a primary therapeutic goal of statin therapy?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Which outcome is a primary therapeutic goal of statin therapy?

Lowering LDL cholesterol is the primary goal of statin therapy because LDL-C is the main modifiable driver of atherosclerotic cardiovascular disease. Statins inhibit HMG-CoA reductase, reducing cholesterol synthesis in the liver. In response, the liver increases LDL receptor expression and clears more LDL particles from the bloodstream, producing a meaningful drop in circulating LDL-C. This reduction in LDL-C is what most benefits cardiovascular outcomes, so it’s sought as the main therapeutic target. Statins can also modestly lower triglycerides and may slightly raise HDL-C, but these changes are secondary to the principal aim of lowering LDL-C. Reducing total cholesterol happens as a result of lowering LDL-C and other lipids, but the most important and direct goal is to reduce LDL-C. Hyperlipidemia describes the condition being treated, not the specific therapeutic target, and increasing HDL-C is not the primary action of statins.

Lowering LDL cholesterol is the primary goal of statin therapy because LDL-C is the main modifiable driver of atherosclerotic cardiovascular disease. Statins inhibit HMG-CoA reductase, reducing cholesterol synthesis in the liver. In response, the liver increases LDL receptor expression and clears more LDL particles from the bloodstream, producing a meaningful drop in circulating LDL-C. This reduction in LDL-C is what most benefits cardiovascular outcomes, so it’s sought as the main therapeutic target.

Statins can also modestly lower triglycerides and may slightly raise HDL-C, but these changes are secondary to the principal aim of lowering LDL-C. Reducing total cholesterol happens as a result of lowering LDL-C and other lipids, but the most important and direct goal is to reduce LDL-C. Hyperlipidemia describes the condition being treated, not the specific therapeutic target, and increasing HDL-C is not the primary action of statins.

More practice questions